Ella Ariza-Heredia, MD

The University of Texas MD Anderson Cancer Center

Disclosure(s): MERCK: Grant/Research Support

Poster(s):

• 2119 - Predictive Value of the Immunodeficiency Scoring Index for COVID-19 Related Outcomes in Hematopoietic Transplant Recipients
  Saturday, October 22, 2022

  12:15 PM – 1:30 PM US ET

• 2121 - The Impact of Donor CMV Serostatus on Outcomes of CMV Infections in the Era of Letermovir
  Saturday, October 22, 2022

  12:15 PM – 1:30 PM US ET

• 2122 - The Impact of HHV-6 DNAemia on hematopoietic cell transplant (HCT) recipients at high risk for CMV reactivation in the era of Letermovir
  Saturday, October 22, 2022

  12:15 PM – 1:30 PM US ET